These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7622921)
1. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Piketty C; Gilquin J; Kazatchkine MD J Infect Dis; 1995 Aug; 172(2):611. PubMed ID: 7622921 [No Abstract] [Full Text] [Related]
2. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus. Marsh BJ Clin Infect Dis; 1997 Sep; 25(3):754-6. PubMed ID: 9314486 [No Abstract] [Full Text] [Related]
3. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071 [TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl. Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246 [No Abstract] [Full Text] [Related]
5. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions. Kletzel M; Beck S; Elser J; Shock N; Burks W Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295 [TBL] [Abstract][Full Text] [Related]
6. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction? Gompels MM; Simpson N; Snow M; Spickett G; Ong E J Infect; 1999 Mar; 38(2):111-5. PubMed ID: 10342651 [TBL] [Abstract][Full Text] [Related]
7. Desensitization to trimethoprim-sulfamethoxazole following lung transplantation. Mann R; Badesch D; Zamora M; Dreskin SC Chest; 1997 Apr; 111(4):1147. PubMed ID: 9106615 [No Abstract] [Full Text] [Related]
8. Management of Hypersensitivity to Trimethoprim-Sulfamethoxazole With an Ultrarapid Desensitization Protocol in HIV Infection. Villarreal-González RV; González-Díaz SN; Canel Paredes A; De Lira-Quezada CE; Rocha-Silva GK; López Méndez A J Investig Allergol Clin Immunol; 2021 Feb; 32(1):66-68. PubMed ID: 34014167 [No Abstract] [Full Text] [Related]
9. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus. Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079 [No Abstract] [Full Text] [Related]
10. Restarting trimethoprim-sulfamethoxazole after a hypersensitivity reaction in patients infected with the human immunodeficiency virus. Everson-Mays RE; Weidle PJ Am J Health Syst Pharm; 1997 Jul; 54(13):1545-50. PubMed ID: 9217946 [No Abstract] [Full Text] [Related]
12. Desensitization to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus. Quirino T; Bonfanti P; Niero F; Rizzardini G; Iemoli E; Milazzo F Clin Infect Dis; 1996 Feb; 22(2):396. PubMed ID: 8838220 [No Abstract] [Full Text] [Related]
13. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010 [TBL] [Abstract][Full Text] [Related]
14. Desensitization to acetazolamide in a patient with previous antimicrobial sulfonamide allergy. Gharib A; Khokhar A; Caperton CV; Hamadani ST Ann Allergy Asthma Immunol; 2017 Mar; 118(3):369-370. PubMed ID: 28089475 [No Abstract] [Full Text] [Related]
15. A severe hypersensitive reaction to trimethoprim-sulfamethoxazole in a patient infected with human immunodeficiency virus. Marinac JS; Stanford JF Clin Infect Dis; 1993 Jan; 16(1):178-9. PubMed ID: 8448304 [No Abstract] [Full Text] [Related]
16. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole. Lin D; Li WK; Rieder MJ Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608 [TBL] [Abstract][Full Text] [Related]
17. Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole. Yilmaz M; Celik AF; Mert A J Infect Chemother; 2007 Apr; 13(2):122-3. PubMed ID: 17458682 [TBL] [Abstract][Full Text] [Related]
18. A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus. Martin GJ; Paparello SF; Decker CF Clin Infect Dis; 1993 Jan; 16(1):175-6. PubMed ID: 8448303 [No Abstract] [Full Text] [Related]
19. "Treating through" hypersensitivity to cotrimoxazole in children with HIV infection. Kreuz W; Güngör T; Lotz C; Funk M; Kornhuber B Lancet; 1990 Aug; 336(8713):508-9. PubMed ID: 1975015 [No Abstract] [Full Text] [Related]
20. Clinical relevance of cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients. Lin KY; Hung CC AIDS; 2015 Oct; 29(16):2213-4. PubMed ID: 26544585 [No Abstract] [Full Text] [Related] [Next] [New Search]